Snca targeted antisense oligonucleotides mediate progression of pathological deposition in alpha synuclein rodent transmission models of Parkinson's disease

被引：0
作者：
Cole, Tracy [2 ]
Paumier, Katrina [3 ]
Zhao, Hien [2 ]
Weihofen, Andreas [1 ]
Kordasiewicz, Holly [2 ]
Swayze, Eric [2 ]
机构：
[1] Biogen, Neurol Res, Cambridge, MA USA
[2] ISIS Pharmaceut, Neurosci Drug Discovery, 2280 Faraday Ave, Carlsbad, CA 92008 USA
[3] Michigan State, Translat Sci & Mol Med, Grand Rapids, MI USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.239
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
    Toenges, Lars
    Szegoe, Eva M.
    Hause, Patrizia
    Saal, Kim-Ann
    Tatenhorst, Lars
    Koch, Jan Christoph
    d'Hedouville, Zara
    Dambeck, Vivian
    Kuegler, Sebastian
    Dohm, Christoph P.
    Baehr, Mathias
    Lingor, Paul
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [42] Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
    Lazaro, Diana F.
    Pavlou, Maria Angeliki S.
    Outeiro, Tiago Fleming
    EXPERIMENTAL NEUROLOGY, 2017, 298 : 162 - 171
  • [43] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
    Nuber, S.
    Petrasch-Parwez, E.
    Winner, B.
    Winkler, J.
    von Hoersten, S.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Gellerich, F. N.
    Riess, O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S122 - S122
  • [44] Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
    Guo, Mengyuan
    Ji, Xunming
    Liu, Jia
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [45] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
    Nuber, S.
    Petrasch-Parwez, E.
    Winner, B.
    Winkler, J.
    von Hoersten, S.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Gellerich, F. N.
    Riess, O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S90 - S90
  • [46] The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations
    Chen, Vivian
    Moncalvo, Malik
    Tringali, Dominic
    Tagliafierro, Lidia
    Shriskanda, Ahila
    Ilich, Ekaterina
    Dong, Wendy
    Kantor, Boris
    Chiba-Falek, Ornit
    HUMAN MOLECULAR GENETICS, 2020, 29 (18) : 3107 - 3121
  • [47] Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease
    Uehara, Takuya
    Choong, Chi-Jing
    Nakamori, Masayuki
    Hayakawa, Hideki
    Nishiyama, Kumiko
    Kasahara, Yuuya
    Baba, Kousuke
    Nagata, Tetsuya
    Yokota, Takanori
    Tsuda, Hiroshi
    Obika, Satoshi
    Mochizuki, Hideki
    SCIENTIFIC REPORTS, 2019, 9
  • [48] Early functional changes induced by overexpression of α-synuclein in monoamine neurons: new therapies for Parkinson's disease using antisense oligonucleotides
    Alarcon Aris, D.
    Galofre, M.
    Ruiz Bronchal, E.
    Ferres Coy, A.
    Montefeltro, A.
    Artigas, F.
    Vila, M.
    Bortolozzi, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S268 - S268
  • [49] Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease
    Takuya Uehara
    Chi-Jing Choong
    Masayuki Nakamori
    Hideki Hayakawa
    Kumiko Nishiyama
    Yuuya Kasahara
    Kousuke Baba
    Tetsuya Nagata
    Takanori Yokota
    Hiroshi Tsuda
    Satoshi Obika
    Hideki Mochizuki
    Scientific Reports, 9
  • [50] VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease
    Chen, Xi
    Tsika, Elpida
    Levine, Nathan
    Moore, Darren J.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
12345